Phocas Financial Corp’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-189,350
Closed -$3.16M 152
2025
Q1
$3.16M Buy
189,350
+89,780
+90% +$1.65M 0.48% 90
2024
Q4
$1.88M Buy
+99,570
New +$1.92M 0.25% 113
2022
Q4
Sell
-398,002
Closed -$4.74M 332
2022
Q3
$4.74M Sell
398,002
-62,715
-14% -$891K 0.73% 59
2022
Q2
$5.86M Buy
460,717
+32,946
+8% +$423K 0.88% 43
2022
Q1
$5.53M Sell
427,771
-6,643
-2% -$87.7K 0.69% 66
2021
Q4
$6.88M Buy
434,414
+52,535
+14% +$897K 0.88% 47
2021
Q3
$7.44M Buy
381,879
+2,791
+0.7% +$55.4K 0.94% 35
2021
Q2
$8.63M Sell
379,088
-17,287
-4% -$359K 1.09% 21
2021
Q1
$7.28M Buy
396,375
+104,647
+36% +$1.72M 0.96% 34
2020
Q4
$4.35M Buy
+291,728
New +$3.81M 0.66% 69

Other funds holding SEM

Phocas Financial Corp's SEM Position: Q2 2025 in Review

Phocas Financial Corp sold out of Select Medical (SEM) in Q2 2025, closing a stake of 189,350 shares — an estimated $3.16M sold.

Phocas Financial Corp first reported a position in SEM in Q4 2020 and held it in 10 quarters. The position peaked at $8.63M in Q2 2021. 262 funds tracked by Wall St. Rank hold SEM as of Q2 2025.

  • Phocas Financial Corp reported no remaining Select Medical position as of Q2 2025 after selling out during the quarter.
  • Phocas Financial Corp sold 189,350 Select Medical shares in Q2 2025, an estimated $3.16M.
  • Phocas Financial Corp first reported a position in Select Medical in Q4 2020 and held it in 10 quarters.
  • Phocas Financial Corp's Select Medical position peaked at $8.63M in Q2 2021.
  • 262 funds tracked by Wall St. Rank held Select Medical as of Q2 2025.

Based on Phocas Financial Corp's 13F filing for Q2 2025, filed 6 Aug 2025.